Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-01-15 14:07 Tx date 2023-07-08 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Warrants Class A Purchase Warrants
55 - Expiration of warrants
|
-1,827 vol |
0 | |
Filed 2024-01-15 14:07 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-70,616 vol |
11,773 | |
Filed 2024-01-15 14:06 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-3,132 vol |
522 | |
Filed 2023-07-21 18:08 Tx date 2023-07-20 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
82,389 | |
Filed 2023-04-05 17:14 Tx date 2023-03-31 |
$AH
Aleafia Health Inc. (formerly Canabo Medical Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+400,063 vol |
1,748,271 | |
Filed 2023-01-04 17:37 Tx date 2022-12-31 |
$AH
Aleafia Health Inc. (formerly Canabo Medical Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+330,325 vol |
1,348,208 | |
Filed 2022-10-03 10:05 Tx date 2022-09-30 |
$AH
Aleafia Health Inc. (formerly Canabo Medical Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+409,785 vol |
1,017,883 | |
Filed 2022-07-04 13:53 Tx date 2022-06-30 |
$AH
Aleafia Health Inc. (formerly Canabo Medical Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+284,128 vol |
608,098 | |
Filed 2022-04-04 13:45 Tx date 2022-03-31 |
$AH
Aleafia Health Inc. (formerly Canabo Medical Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+250,107 vol |
323,970 | |
Filed 2022-03-05 23:39 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,000 vol |
62,389 | |
Filed 2022-03-05 11:31 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,000 vol |
||
Filed 2022-03-05 11:31 Tx date 2022-02-28 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,000 vol |
62,389 | |
Filed 2021-11-16 16:38 Tx date 2021-11-15 |
$AH
Aleafia Health Inc. (formerly Canabo Medical Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,850
+10,000 vol $0.185 each |
10,000 | |
Filed 2021-11-16 16:37 Tx date 2021-01-31 |
$AH
Aleafia Health Inc. (formerly Canabo Medical Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-10-21 20:22 Tx date 2021-10-01 |
$AH
Aleafia Health Inc. (formerly Canabo Medical Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+33,966 vol |
73,863 | |
Filed 2021-07-16 17:20 Tx date 2021-07-01 |
$AH
Aleafia Health Inc. (formerly Canabo Medical Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+25,434 vol |
39,897 | |
Filed 2021-04-27 21:29 Tx date 2021-04-22 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
51,389 | |
Filed 2021-03-31 21:24 Tx date 2021-01-31 |
$AH
Aleafia Health Inc. (formerly Canabo Medical Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
14,463 | ||
Filed 2021-02-10 21:39 Tx date 2021-01-31 |
$AH
Aleafia Health Inc. (formerly Canabo Medical Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
34,000 | ||
Filed 2020-11-09 22:21 Tx date 2020-11-05 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$4,872
+1,218 vol $4.00 each |
3,654 | |
Filed 2020-11-09 22:19 Tx date 2020-11-05 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Warrants Class B Purchase Warrants
54 - Exercise of warrants
|
-1,218 vol |
0 | |
Filed 2020-10-15 16:15 Tx date 2020-10-13 |
$EDSA
Edesa Biotech, Inc. |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$148,800
+20,000 vol $7.44 each |
31,389 | |
Filed 2020-02-15 18:01 Tx date 2020-02-12 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+11,389 vol |
11,389 | |
Filed 2020-01-14 09:43 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+1,218 vol |
1,218 | |
Filed 2020-01-13 23:36 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+1,218 vol |
1,218 | |
Filed 2020-01-13 23:36 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Warrants Class B Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+1,218 vol |
||
Filed 2020-01-13 23:35 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Warrants Class B Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-01-13 23:34 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Warrants Class A Purchase Warrants
11 - Acquisition or disposition carried out privately
|
+1,827 vol |
1,827 | |
Filed 2020-01-13 23:33 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Warrants Class A Purchase Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-01-13 23:33 Tx date 2020-01-08 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,002
+2,436 vol $4.11 each |
2,436 | |
Filed 2020-01-13 23:32 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Holder: York-Cav Enterprises Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-06-25 10:12 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-06-25 10:12 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-06-25 10:12 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) |
Sistilli, Carlo
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|